Although ALCAR exerts antioxidant activities in rodents, it is not known whether taking high doses of ALCAR will have similar effects in humans
Specifically, central administration of GLP-1R antagonists block LiCl-induced c-Fos, hypophagia, and pica (37, 41)
Its hair-relevant evidence is largely mechanistic and indirect, drawn from the same properties documented in its extensive skin and wound-healing literature VEGF upregulation, angiogenesis, anti-inflammatory and antioxidant effects, stimulation of fibroblasts and extracellular-matrix synthesis, and broad gene-expression modulation
CagriSema (cagrilintide + semaglutide) has Phase 3 trial data but uses a weaker incretin backbone (just GLP-1)
Chang Gung Medical Journal 34.5 (2011): 449-460